Taiho Oncology, Inc.
Christopher Gebert, MBA, is an accomplished professional with extensive experience in outsourcing and vendor management, currently serving as Manager, Outsourcing & Vendor Management at Taiho Oncology, Inc. since January 2024. Prior to this role, Christopher held multiple positions at Astex Pharmaceuticals from April 2015 to December 2023, including Manager, Vendor Management and Senior Budget Analyst, where responsibilities encompassed budget negotiations and financial tracking for clinical studies. Earlier career experience at Exelixis, Inc. involved similar roles where Christopher managed budgets and contracts with Contract Research Organizations. Christopher began a career in sports management with internship roles at the University of California, Riverside and Huntsville Stars Baseball Club. Christopher holds an MBA from the University of Arizona and a Bachelor's Degree in Business Administration from the University of California, Riverside.
This person is not in any teams
This person is not in any offices
Taiho Oncology, Inc.
2 followers
The mission of Taiho Oncology, Inc. is to improve the lives of patients with cancer, their families and their caregivers. The company specializes in the development of orally administered anti-cancer agents and markets these medicines for a range of tumor types in the U.S. Taiho Oncology’s growing pipeline of selectively targeted anti-cancer agents is led by a world-class clinical development organization. Taiho Oncology is a subsidiary of Taiho Pharmaceutical Co., Ltd. which is part of Otsuka Holdings Co., Ltd. Taiho Oncology is headquartered in Princeton, New Jersey and oversees its parent company’s European and Canadian operations, which are located in Zug, Switzerland and Oakville, Ontario, Canada. For more information, visit www.taihooncology.com